Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 70 Tumor-Agnostic 2 Other solid neoplasm 1 NET 1 Endocrine 1 Dermatologic 1

Conditions

Pancreatic Neoplasms 1 Neoplasms, Basal Cell 1

Interventions

pembrolizumab 339 Nivolumab 305 Ipilimumab 274 Cyclophosphamide 194 aldesleukin 148 Interleukin-2 110 fludarabine phosphate 106 trametinib 85 Temozolomide 83 Dacarbazine 81 fludarabine 80 dabrafenib 77 Radiotherapy 75 Biopsy 75 Vemurafenib 71 Imiquimod 53 Bevacizumab 51 sargramostim 50 Radiosurgery 49 Peripheral Blood Stem Cell Transplantation 49 Paclitaxel 49 Magnetic Resonance Spectroscopy 49 Aminolevulinic Acid 49 binimetinib 48 Carboplatin 48 Specimen Handling 47 Blood Specimen Collection 47 cemiplimab 46 Cisplatin 45 3-ingenyl angelate 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

folfirinox × Dermatologic × Clear all

NCT06483555 2026-04-23

PANGEA

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Recruiting

DermatologicGastrointestinal

Pancreatic Neoplasms, Neoplasms, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡